Literature DB >> 336138

Progress in myasthenia gravis.

C W Havard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 336138      PMCID: PMC1631790          DOI: 10.1136/bmj.2.6093.1008

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  30 in total

1.  AN ELECTROPHYSIOLOGICAL INVESTIGATION OF NEUROMUSCULAR TRANSMISSION IN MYASTHENIA GRAVIS.

Authors:  D ELMQVIST; W W HOFMANN; J KUGELBERG; D M QUASTEL
Journal:  J Physiol       Date:  1964-11       Impact factor: 5.182

2.  IMMUNOLOGICAL DISTURBANCES IN MYASTHENIA GRAVIS WITH A REPORT OF HASHIMOTO'S DISEASE DEVELOPING AFTER THYMECTOMY.

Authors:  J A SIMPSON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1964-12       Impact factor: 10.154

3.  Search for a neuromuscular blocking agent in the blood of patients with myasthenia gravis.

Authors:  W L NASTUK; A J STRAUSS; K E OSSERMAN
Journal:  Am J Med       Date:  1959-03       Impact factor: 4.965

4.  Corticosteroids in management of severe, generalized myasthenia gravis. Effectiveness and comparison with corticotropin therapy.

Authors:  N G Brunner; T Namba; D Grob
Journal:  Neurology       Date:  1972-06       Impact factor: 9.910

5.  Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors.

Authors:  R R Almon; C G Andrew; S H Appel
Journal:  Science       Date:  1974-10-04       Impact factor: 47.728

6.  Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors.

Authors:  D M Fambrough; D B Drachman; S Satyamurti
Journal:  Science       Date:  1973-10-19       Impact factor: 47.728

7.  Gradually increasing doses of prednisone in myasthenia gravis. Reducing the hazards of treatment.

Authors:  M E Seybold; D B Drachman
Journal:  N Engl J Med       Date:  1974-01-10       Impact factor: 91.245

8.  Autoimmune response to acetylcholine receptor.

Authors:  J Patrick; J Lindstrom
Journal:  Science       Date:  1973-05-25       Impact factor: 47.728

Review 9.  Myasthenia gravis as an autoimmune disease: clinical aspects.

Authors:  J A Simpson
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

10.  Myasthenia gravis: evaluation of treatment in 1,355 patients.

Authors:  V P Perlo; D C Poskanzer; R S Schwab; H R Viets; K E Osserman; G Genkins
Journal:  Neurology       Date:  1966-05       Impact factor: 9.910

View more
  1 in total

1.  Clinical and electromyographic characteristics of pathological muscular-fatigue syndromes of the myasthenia type.

Authors:  L B Perel'man; E G Almazova; L F Kasatkina; E A Kolomenskaya; L V Nozdracheva; B M Gekht
Journal:  Neurosci Behav Physiol       Date:  1984 Jul-Aug
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.